Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Porifera | 49 | 2021 | 58 | 9.320 |
Why?
|
Biological Products | 21 | 2021 | 78 | 6.650 |
Why?
|
Carbazoles | 17 | 2021 | 46 | 4.590 |
Why?
|
Antineoplastic Agents | 24 | 2022 | 1070 | 4.250 |
Why?
|
Depsipeptides | 10 | 2022 | 21 | 3.830 |
Why?
|
Alkaloids | 16 | 2014 | 40 | 3.710 |
Why?
|
Antimalarials | 21 | 2014 | 71 | 3.370 |
Why?
|
Marine Biology | 20 | 2019 | 23 | 3.360 |
Why?
|
Anti-Infective Agents | 14 | 2022 | 166 | 3.270 |
Why?
|
Molecular Structure | 48 | 2022 | 397 | 3.170 |
Why?
|
Indole Alkaloids | 9 | 2019 | 18 | 3.090 |
Why?
|
Anti-Bacterial Agents | 19 | 2020 | 1026 | 2.240 |
Why?
|
Antiviral Agents | 10 | 2021 | 211 | 2.180 |
Why?
|
Antifungal Agents | 15 | 2022 | 108 | 2.170 |
Why?
|
Antiprotozoal Agents | 12 | 2014 | 23 | 2.020 |
Why?
|
Animals | 99 | 2022 | 20881 | 1.920 |
Why?
|
Aquatic Organisms | 6 | 2021 | 9 | 1.870 |
Why?
|
Plasmodium falciparum | 17 | 2014 | 45 | 1.810 |
Why?
|
Anti-HIV Agents | 10 | 2008 | 135 | 1.700 |
Why?
|
Kadsura | 5 | 2019 | 9 | 1.660 |
Why?
|
Drug Discovery | 8 | 2021 | 94 | 1.600 |
Why?
|
Carbolines | 8 | 2009 | 19 | 1.510 |
Why?
|
Triterpenes | 4 | 2017 | 40 | 1.490 |
Why?
|
Antidepressive Agents | 5 | 2020 | 216 | 1.440 |
Why?
|
Plant Extracts | 7 | 2018 | 122 | 1.400 |
Why?
|
Endangered Species | 3 | 2013 | 9 | 1.310 |
Why?
|
Peptides, Cyclic | 7 | 2011 | 35 | 1.240 |
Why?
|
Structure-Activity Relationship | 17 | 2020 | 420 | 1.220 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2021 | 300 | 1.200 |
Why?
|
Microbial Sensitivity Tests | 20 | 2019 | 226 | 1.180 |
Why?
|
Magnetic Resonance Spectroscopy | 22 | 2021 | 346 | 1.150 |
Why?
|
Antineoplastic Agents, Phytogenic | 5 | 2018 | 88 | 1.130 |
Why?
|
Mycobacterium tuberculosis | 11 | 2018 | 103 | 1.130 |
Why?
|
Sesquiterpenes | 8 | 2018 | 41 | 1.120 |
Why?
|
Mollusca | 5 | 2022 | 14 | 1.110 |
Why?
|
Cryptococcus neoformans | 6 | 2022 | 24 | 1.040 |
Why?
|
Stereoisomerism | 16 | 2019 | 169 | 1.040 |
Why?
|
Drug Screening Assays, Antitumor | 14 | 2019 | 111 | 1.030 |
Why?
|
Protective Agents | 3 | 2021 | 36 | 0.930 |
Why?
|
Biological Factors | 4 | 2005 | 11 | 0.910 |
Why?
|
N,N-Dimethyltryptamine | 2 | 2017 | 2 | 0.910 |
Why?
|
Hydrocarbons, Brominated | 2 | 2017 | 7 | 0.900 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 3 | 2009 | 64 | 0.900 |
Why?
|
Indoles | 6 | 2017 | 146 | 0.890 |
Why?
|
Pyrans | 2 | 2015 | 16 | 0.890 |
Why?
|
Antitubercular Agents | 8 | 2018 | 57 | 0.880 |
Why?
|
HIV-1 | 7 | 2007 | 177 | 0.870 |
Why?
|
Lindera | 2 | 2013 | 3 | 0.860 |
Why?
|
Chlorophyta | 2 | 2015 | 5 | 0.860 |
Why?
|
Naphthyridines | 3 | 2008 | 20 | 0.860 |
Why?
|
Inhibitory Concentration 50 | 15 | 2016 | 73 | 0.820 |
Why?
|
Chromatography, Thin Layer | 1 | 2021 | 52 | 0.810 |
Why?
|
Metabolomics | 1 | 2021 | 28 | 0.800 |
Why?
|
Terpenes | 4 | 2021 | 18 | 0.790 |
Why?
|
Humans | 70 | 2022 | 68618 | 0.780 |
Why?
|
Orchidaceae | 1 | 2021 | 2 | 0.770 |
Why?
|
Succinates | 1 | 2021 | 9 | 0.760 |
Why?
|
Pyrroles | 6 | 2007 | 83 | 0.750 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2019 | 92 | 0.740 |
Why?
|
Cell Line, Tumor | 11 | 2020 | 1851 | 0.720 |
Why?
|
Symbiosis | 1 | 2020 | 19 | 0.720 |
Why?
|
Betacoronavirus | 1 | 2021 | 116 | 0.710 |
Why?
|
Thiazolidines | 3 | 2009 | 23 | 0.710 |
Why?
|
Immune System | 4 | 2009 | 63 | 0.690 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 14 | 2018 | 85 | 0.680 |
Why?
|
Receptors, Serotonin | 2 | 2017 | 74 | 0.670 |
Why?
|
Hep G2 Cells | 6 | 2021 | 68 | 0.670 |
Why?
|
Peptides | 4 | 2017 | 455 | 0.660 |
Why?
|
Kaempferols | 3 | 2019 | 3 | 0.660 |
Why?
|
Colonic Neoplasms | 4 | 2018 | 299 | 0.660 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 157 | 0.650 |
Why?
|
Models, Chemical | 3 | 2019 | 155 | 0.650 |
Why?
|
Nervous System | 3 | 2009 | 45 | 0.650 |
Why?
|
Lactones | 4 | 2022 | 64 | 0.650 |
Why?
|
Glycogen Synthase Kinase 3 | 3 | 2008 | 64 | 0.640 |
Why?
|
Plants, Medicinal | 4 | 2014 | 43 | 0.640 |
Why?
|
Food Coloring Agents | 1 | 2018 | 2 | 0.640 |
Why?
|
Liver Neoplasms | 2 | 2022 | 334 | 0.640 |
Why?
|
Citrus | 1 | 2018 | 12 | 0.630 |
Why?
|
Chromatography, High Pressure Liquid | 7 | 2018 | 381 | 0.620 |
Why?
|
Indonesia | 7 | 2021 | 11 | 0.620 |
Why?
|
Diterpenes | 3 | 2014 | 42 | 0.620 |
Why?
|
Cardiovascular System | 3 | 2009 | 85 | 0.620 |
Why?
|
Cell Proliferation | 5 | 2018 | 1174 | 0.610 |
Why?
|
Peptide Biosynthesis | 1 | 2017 | 5 | 0.600 |
Why?
|
Molecular Conformation | 9 | 2021 | 128 | 0.580 |
Why?
|
Actins | 2 | 2009 | 249 | 0.580 |
Why?
|
Anti-Inflammatory Agents | 5 | 2007 | 234 | 0.570 |
Why?
|
Apoptosis | 4 | 2020 | 1641 | 0.550 |
Why?
|
Fusarium | 2 | 2014 | 5 | 0.550 |
Why?
|
Models, Molecular | 11 | 2018 | 546 | 0.540 |
Why?
|
Plasmodium berghei | 4 | 2010 | 7 | 0.540 |
Why?
|
Cornus | 2 | 2014 | 2 | 0.530 |
Why?
|
Seawater | 2 | 2013 | 29 | 0.530 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 332 | 0.520 |
Why?
|
beta Catenin | 2 | 2018 | 73 | 0.520 |
Why?
|
Circular Dichroism | 7 | 2019 | 99 | 0.520 |
Why?
|
Leishmania donovani | 8 | 2012 | 19 | 0.520 |
Why?
|
Quinones | 2 | 2018 | 13 | 0.510 |
Why?
|
Eutrophication | 1 | 2015 | 5 | 0.510 |
Why?
|
Mice | 20 | 2022 | 8474 | 0.510 |
Why?
|
Acetaminophen | 3 | 2022 | 111 | 0.510 |
Why?
|
Drug Resistance, Fungal | 2 | 2016 | 8 | 0.500 |
Why?
|
Neoplasms | 2 | 2022 | 1667 | 0.480 |
Why?
|
Persea | 1 | 2014 | 1 | 0.480 |
Why?
|
Jatropha | 1 | 2014 | 1 | 0.480 |
Why?
|
Apocynaceae | 1 | 2014 | 2 | 0.480 |
Why?
|
Alzheimer Disease | 3 | 2014 | 565 | 0.480 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 362 | 0.480 |
Why?
|
Enzyme Inhibitors | 5 | 2021 | 659 | 0.470 |
Why?
|
Tyrosine | 2 | 2005 | 196 | 0.470 |
Why?
|
Vibrio | 2 | 2013 | 14 | 0.460 |
Why?
|
Asteraceae | 1 | 2013 | 4 | 0.460 |
Why?
|
Crystallography, X-Ray | 8 | 2018 | 190 | 0.450 |
Why?
|
Dinoflagellida | 2 | 2010 | 5 | 0.450 |
Why?
|
Monoterpenes | 1 | 2013 | 8 | 0.440 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 498 | 0.440 |
Why?
|
Hydroquinones | 1 | 2013 | 15 | 0.440 |
Why?
|
Pyrroloiminoquinones | 1 | 2013 | 1 | 0.440 |
Why?
|
Tyramine | 2 | 2004 | 16 | 0.430 |
Why?
|
Geologic Sediments | 1 | 2013 | 75 | 0.430 |
Why?
|
Mycobacterium avium Complex | 2 | 2009 | 16 | 0.420 |
Why?
|
Methicillin Resistance | 2 | 2009 | 45 | 0.420 |
Why?
|
Anti-Anxiety Agents | 2 | 2010 | 107 | 0.420 |
Why?
|
Ticks | 1 | 2012 | 13 | 0.420 |
Why?
|
Culicidae | 1 | 2012 | 12 | 0.420 |
Why?
|
Insect Repellents | 1 | 2012 | 8 | 0.420 |
Why?
|
Nitro Compounds | 1 | 2012 | 11 | 0.410 |
Why?
|
Volatile Organic Compounds | 1 | 2012 | 14 | 0.410 |
Why?
|
Iridoid Glycosides | 1 | 2012 | 1 | 0.410 |
Why?
|
Orphan Nuclear Receptors | 1 | 2012 | 5 | 0.410 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 7 | 0.410 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 133 | 0.410 |
Why?
|
Glycosides | 2 | 2022 | 14 | 0.400 |
Why?
|
Polyketides | 3 | 2018 | 3 | 0.380 |
Why?
|
Ascomycota | 2 | 2022 | 8 | 0.380 |
Why?
|
Molecular Docking Simulation | 4 | 2021 | 78 | 0.380 |
Why?
|
Bacillus megaterium | 2 | 2000 | 2 | 0.370 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2010 | 35 | 0.370 |
Why?
|
Staphylococcal Infections | 3 | 2019 | 156 | 0.360 |
Why?
|
Marine Toxins | 1 | 2010 | 14 | 0.360 |
Why?
|
Neurogenic Inflammation | 1 | 2010 | 4 | 0.350 |
Why?
|
Cerebellar Diseases | 1 | 2010 | 6 | 0.350 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2009 | 5 | 0.350 |
Why?
|
Ostreidae | 1 | 2009 | 7 | 0.350 |
Why?
|
Shellfish | 1 | 2009 | 8 | 0.350 |
Why?
|
Phytotherapy | 3 | 2013 | 53 | 0.350 |
Why?
|
Trees | 1 | 2009 | 8 | 0.350 |
Why?
|
Heterocyclic Compounds, 4 or More Rings | 1 | 2010 | 34 | 0.350 |
Why?
|
Bacteria | 4 | 2020 | 193 | 0.350 |
Why?
|
Food Handling | 1 | 2009 | 34 | 0.340 |
Why?
|
Carbon Dioxide | 1 | 2009 | 78 | 0.340 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 317 | 0.340 |
Why?
|
Antiparasitic Agents | 2 | 2007 | 12 | 0.340 |
Why?
|
Lignans | 2 | 2019 | 10 | 0.330 |
Why?
|
Oils, Volatile | 3 | 2012 | 9 | 0.330 |
Why?
|
Amides | 1 | 2009 | 86 | 0.330 |
Why?
|
Mass Spectrometry | 5 | 2021 | 284 | 0.320 |
Why?
|
Urochordata | 1 | 2008 | 4 | 0.320 |
Why?
|
Alaska | 3 | 2019 | 7 | 0.320 |
Why?
|
Cell Survival | 4 | 2021 | 901 | 0.320 |
Why?
|
Jamaica | 6 | 2006 | 10 | 0.320 |
Why?
|
Prodrugs | 1 | 2008 | 54 | 0.310 |
Why?
|
Drugs, Investigational | 2 | 2004 | 18 | 0.300 |
Why?
|
Receptor, ErbB-3 | 1 | 2007 | 17 | 0.300 |
Why?
|
Dioxanes | 2 | 2011 | 15 | 0.290 |
Why?
|
Oceans and Seas | 5 | 2014 | 10 | 0.290 |
Why?
|
Tumor Cells, Cultured | 8 | 2006 | 852 | 0.290 |
Why?
|
X-Ray Diffraction | 2 | 2017 | 53 | 0.290 |
Why?
|
Anxiety | 1 | 2010 | 422 | 0.290 |
Why?
|
Bacterial Proteins | 2 | 2019 | 245 | 0.280 |
Why?
|
Lysosomes | 1 | 2007 | 136 | 0.280 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 201 | 0.280 |
Why?
|
Araceae | 1 | 2006 | 1 | 0.280 |
Why?
|
Dreissena | 1 | 2006 | 1 | 0.280 |
Why?
|
Hawaii | 3 | 2013 | 24 | 0.280 |
Why?
|
Communicable Diseases | 1 | 2007 | 50 | 0.270 |
Why?
|
Streptomyces | 1 | 2006 | 15 | 0.270 |
Why?
|
Anticonvulsants | 1 | 2008 | 223 | 0.270 |
Why?
|
Apiaceae | 2 | 2008 | 2 | 0.270 |
Why?
|
Parasitic Diseases | 1 | 2005 | 9 | 0.260 |
Why?
|
Vero Cells | 4 | 2008 | 13 | 0.260 |
Why?
|
Polyenes | 1 | 2005 | 2 | 0.260 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 240 | 0.260 |
Why?
|
Oxygen | 1 | 2007 | 386 | 0.260 |
Why?
|
Ecosystem | 3 | 2020 | 54 | 0.260 |
Why?
|
Thiazoles | 1 | 2006 | 95 | 0.260 |
Why?
|
Liver | 3 | 2022 | 1118 | 0.260 |
Why?
|
Spectrophotometry, Ultraviolet | 5 | 2008 | 79 | 0.250 |
Why?
|
DNA | 1 | 2008 | 597 | 0.250 |
Why?
|
Bivalvia | 1 | 2004 | 10 | 0.250 |
Why?
|
Mycoses | 1 | 2005 | 60 | 0.250 |
Why?
|
Plant Leaves | 4 | 2018 | 49 | 0.250 |
Why?
|
Protein Synthesis Inhibitors | 2 | 2019 | 32 | 0.240 |
Why?
|
Water | 2 | 2018 | 230 | 0.240 |
Why?
|
Fungi | 2 | 2020 | 27 | 0.240 |
Why?
|
Nervous System Diseases | 1 | 2005 | 142 | 0.240 |
Why?
|
Quinolines | 1 | 2004 | 48 | 0.230 |
Why?
|
Ceramides | 1 | 2008 | 578 | 0.230 |
Why?
|
Drug Design | 3 | 2014 | 107 | 0.230 |
Why?
|
Administration, Oral | 4 | 2013 | 411 | 0.230 |
Why?
|
Pharmacognosy | 1 | 2003 | 2 | 0.230 |
Why?
|
Computer Simulation | 3 | 2016 | 706 | 0.230 |
Why?
|
Protein Biosynthesis | 2 | 2019 | 181 | 0.230 |
Why?
|
Spiro Compounds | 2 | 2016 | 14 | 0.230 |
Why?
|
Cystine | 2 | 2014 | 20 | 0.230 |
Why?
|
Nucleosides | 1 | 2003 | 9 | 0.220 |
Why?
|
Drug Resistance, Bacterial | 1 | 2004 | 98 | 0.220 |
Why?
|
Depression | 1 | 2010 | 943 | 0.220 |
Why?
|
Daphne | 1 | 2022 | 1 | 0.220 |
Why?
|
Antifreeze Proteins | 1 | 2002 | 3 | 0.220 |
Why?
|
Magnoliopsida | 2 | 2015 | 5 | 0.220 |
Why?
|
China | 2 | 2021 | 138 | 0.210 |
Why?
|
Ergosterol | 1 | 2002 | 3 | 0.210 |
Why?
|
Biotransformation | 4 | 2007 | 69 | 0.210 |
Why?
|
Pharmacology | 1 | 2002 | 9 | 0.210 |
Why?
|
Plant Roots | 2 | 2019 | 22 | 0.200 |
Why?
|
Phylogeography | 1 | 2021 | 4 | 0.200 |
Why?
|
Binding Sites | 4 | 2018 | 631 | 0.200 |
Why?
|
Bromobenzenes | 1 | 2001 | 4 | 0.200 |
Why?
|
Databases, Chemical | 1 | 2021 | 3 | 0.200 |
Why?
|
Principal Component Analysis | 1 | 2021 | 55 | 0.200 |
Why?
|
Cyclooctanes | 2 | 2019 | 5 | 0.200 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2021 | 3 | 0.200 |
Why?
|
Spectrum Analysis | 4 | 2005 | 81 | 0.200 |
Why?
|
Databases, Protein | 1 | 2021 | 49 | 0.200 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 223 | 0.190 |
Why?
|
Protein Interaction Mapping | 1 | 2021 | 62 | 0.190 |
Why?
|
Cluster Analysis | 1 | 2021 | 219 | 0.190 |
Why?
|
Phytochemicals | 1 | 2021 | 6 | 0.190 |
Why?
|
Cunninghamella | 1 | 2000 | 1 | 0.190 |
Why?
|
Rats | 6 | 2018 | 5300 | 0.190 |
Why?
|
Furans | 2 | 2003 | 27 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.190 |
Why?
|
HeLa Cells | 2 | 2020 | 237 | 0.190 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2022 | 131 | 0.190 |
Why?
|
Flavonoids | 2 | 2022 | 109 | 0.180 |
Why?
|
Ligands | 1 | 2021 | 317 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 331 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2014 | 1745 | 0.180 |
Why?
|
Anthelmintics | 3 | 2007 | 8 | 0.180 |
Why?
|
Lipids | 1 | 2022 | 298 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 163 | 0.180 |
Why?
|
Calcium | 4 | 2013 | 929 | 0.180 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 247 | 0.180 |
Why?
|
Propylamines | 1 | 2000 | 22 | 0.180 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 70 | 0.180 |
Why?
|
Rosales | 1 | 2000 | 2 | 0.180 |
Why?
|
Botrytis | 1 | 2000 | 2 | 0.180 |
Why?
|
Melanoma | 2 | 2000 | 335 | 0.180 |
Why?
|
Computational Biology | 1 | 2021 | 190 | 0.180 |
Why?
|
Hepatitis B | 2 | 2015 | 42 | 0.180 |
Why?
|
Rhamnose | 1 | 2019 | 1 | 0.170 |
Why?
|
Picrates | 2 | 2018 | 2 | 0.170 |
Why?
|
Stilbenes | 1 | 2000 | 57 | 0.170 |
Why?
|
Candida albicans | 4 | 2016 | 39 | 0.170 |
Why?
|
Peroxides | 2 | 2014 | 23 | 0.170 |
Why?
|
Bridged Bicyclo Compounds | 1 | 1999 | 29 | 0.170 |
Why?
|
Leukemia P388 | 4 | 2006 | 4 | 0.170 |
Why?
|
Xanthones | 1 | 1998 | 2 | 0.160 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1999 | 82 | 0.160 |
Why?
|
Malaria | 3 | 2006 | 26 | 0.160 |
Why?
|
Biphenyl Compounds | 2 | 2018 | 184 | 0.160 |
Why?
|
Quantum Theory | 1 | 2018 | 21 | 0.160 |
Why?
|
Chemoprevention | 1 | 2018 | 26 | 0.160 |
Why?
|
Penicillium | 1 | 2018 | 3 | 0.160 |
Why?
|
Morus | 1 | 2018 | 2 | 0.160 |
Why?
|
Parasitic Sensitivity Tests | 2 | 2008 | 8 | 0.150 |
Why?
|
Catalytic Domain | 3 | 2018 | 99 | 0.150 |
Why?
|
Catalysis | 2 | 2012 | 123 | 0.150 |
Why?
|
Food | 1 | 2018 | 52 | 0.150 |
Why?
|
Wnt Signaling Pathway | 1 | 2018 | 57 | 0.150 |
Why?
|
Glycogen Synthase Kinase 3 beta | 2 | 2008 | 57 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2007 | 373 | 0.150 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 112 | 0.150 |
Why?
|
Acetamides | 1 | 2017 | 17 | 0.150 |
Why?
|
Anticoagulants | 3 | 2007 | 356 | 0.150 |
Why?
|
Proteomics | 1 | 2019 | 246 | 0.150 |
Why?
|
Amino Acid Sequence | 4 | 2014 | 1083 | 0.140 |
Why?
|
Molecular Sequence Data | 5 | 2013 | 1447 | 0.140 |
Why?
|
Fatty Acid Synthases | 1 | 2016 | 6 | 0.140 |
Why?
|
Cnidaria | 1 | 1996 | 2 | 0.140 |
Why?
|
Piperidones | 1 | 2016 | 2 | 0.140 |
Why?
|
Invertebrates | 2 | 2007 | 8 | 0.130 |
Why?
|
Virus Replication | 2 | 2015 | 104 | 0.130 |
Why?
|
Mississippi | 3 | 2014 | 11 | 0.130 |
Why?
|
Ebolavirus | 1 | 2015 | 2 | 0.130 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2015 | 9 | 0.130 |
Why?
|
Dengue | 1 | 2015 | 5 | 0.130 |
Why?
|
Combinatorial Chemistry Techniques | 2 | 2007 | 25 | 0.130 |
Why?
|
Female | 6 | 2021 | 38074 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2015 | 43 | 0.130 |
Why?
|
Hydrolysis | 1 | 2015 | 144 | 0.130 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2006 | 85 | 0.120 |
Why?
|
HIV | 3 | 2001 | 56 | 0.120 |
Why?
|
Papillomaviridae | 1 | 2015 | 104 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2015 | 123 | 0.120 |
Why?
|
Iridoid Glucosides | 1 | 2014 | 1 | 0.120 |
Why?
|
Iridoids | 1 | 2014 | 4 | 0.120 |
Why?
|
Calibration | 2 | 2006 | 73 | 0.120 |
Why?
|
Cryptococcus | 1 | 2014 | 7 | 0.120 |
Why?
|
United States | 2 | 2020 | 7367 | 0.120 |
Why?
|
Acetylcholinesterase | 1 | 2014 | 19 | 0.120 |
Why?
|
Norisoprenoids | 1 | 2014 | 7 | 0.120 |
Why?
|
Rhododendron | 1 | 2014 | 3 | 0.120 |
Why?
|
Meteorology | 1 | 2014 | 1 | 0.120 |
Why?
|
Coral Reefs | 1 | 2014 | 2 | 0.120 |
Why?
|
HMGB1 Protein | 1 | 2014 | 23 | 0.120 |
Why?
|
Cyclohexanones | 1 | 2014 | 9 | 0.120 |
Why?
|
Glucosides | 1 | 2014 | 16 | 0.120 |
Why?
|
Cystine-Knot Miniproteins | 1 | 2013 | 1 | 0.120 |
Why?
|
Water Pollutants | 1 | 2014 | 31 | 0.120 |
Why?
|
Crystallization | 2 | 2004 | 57 | 0.110 |
Why?
|
Gastropoda | 1 | 2013 | 2 | 0.110 |
Why?
|
Mycoplasma | 1 | 2013 | 10 | 0.110 |
Why?
|
Temperature | 2 | 2018 | 341 | 0.110 |
Why?
|
Species Specificity | 1 | 2014 | 303 | 0.110 |
Why?
|
Cyanobacteria | 2 | 2003 | 4 | 0.110 |
Why?
|
Down-Regulation | 1 | 2015 | 447 | 0.110 |
Why?
|
Epigenomics | 1 | 2013 | 29 | 0.110 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 504 | 0.110 |
Why?
|
Kinetics | 5 | 2018 | 1047 | 0.110 |
Why?
|
Hydrogen Bonding | 1 | 2013 | 67 | 0.110 |
Why?
|
Hexanes | 1 | 2012 | 7 | 0.100 |
Why?
|
Amyloid beta-Peptides | 1 | 2014 | 191 | 0.100 |
Why?
|
Environmental Monitoring | 1 | 2014 | 180 | 0.100 |
Why?
|
Colony Count, Microbial | 2 | 2009 | 77 | 0.100 |
Why?
|
Alkylation | 1 | 2012 | 26 | 0.100 |
Why?
|
Pneumonia, Viral | 1 | 2015 | 154 | 0.100 |
Why?
|
Cardiovascular Agents | 2 | 2003 | 82 | 0.100 |
Why?
|
Agelas | 1 | 2012 | 1 | 0.100 |
Why?
|
Chickens | 2 | 2016 | 232 | 0.100 |
Why?
|
Liver X Receptors | 1 | 2012 | 8 | 0.100 |
Why?
|
Arctic Regions | 1 | 2011 | 4 | 0.100 |
Why?
|
CHO Cells | 1 | 2012 | 161 | 0.100 |
Why?
|
Cricetinae | 1 | 2012 | 262 | 0.100 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 322 | 0.100 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2003 | 73 | 0.100 |
Why?
|
Sepsis | 1 | 2014 | 233 | 0.090 |
Why?
|
Harmful Algal Bloom | 1 | 2010 | 1 | 0.090 |
Why?
|
Pentacyclic Triterpenes | 2 | 2000 | 3 | 0.090 |
Why?
|
Lactams | 1 | 2010 | 4 | 0.090 |
Why?
|
Tryptamines | 1 | 2010 | 7 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2008 | 137 | 0.090 |
Why?
|
Indian Ocean | 2 | 2008 | 8 | 0.090 |
Why?
|
Mice, Nude | 1 | 2011 | 294 | 0.090 |
Why?
|
Disease Models, Animal | 2 | 2008 | 2550 | 0.090 |
Why?
|
Pyrrolidines | 1 | 2010 | 45 | 0.090 |
Why?
|
Time Factors | 3 | 2009 | 4655 | 0.090 |
Why?
|
Baccharis | 1 | 2010 | 1 | 0.090 |
Why?
|
Serotonin Receptor Agonists | 1 | 2010 | 34 | 0.090 |
Why?
|
Spectrophotometry, Infrared | 3 | 2000 | 25 | 0.090 |
Why?
|
Hydrostatic Pressure | 1 | 2009 | 11 | 0.090 |
Why?
|
Piperidines | 1 | 2010 | 123 | 0.090 |
Why?
|
Food Microbiology | 1 | 2009 | 24 | 0.090 |
Why?
|
Consumer Product Safety | 1 | 2009 | 32 | 0.090 |
Why?
|
Rhodophyta | 1 | 2009 | 1 | 0.090 |
Why?
|
Leishmania | 1 | 2009 | 6 | 0.090 |
Why?
|
Food Contamination | 1 | 2009 | 56 | 0.090 |
Why?
|
Trypanocidal Agents | 1 | 2009 | 11 | 0.090 |
Why?
|
Taste | 1 | 2009 | 49 | 0.090 |
Why?
|
Consumer Behavior | 1 | 2009 | 68 | 0.080 |
Why?
|
Hepacivirus | 1 | 2010 | 90 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2006 | 2077 | 0.080 |
Why?
|
Sesquiterpenes, Guaiane | 1 | 2008 | 3 | 0.080 |
Why?
|
Zebrafish | 1 | 2010 | 187 | 0.080 |
Why?
|
Furocoumarins | 1 | 2008 | 9 | 0.080 |
Why?
|
Spectrometry, Mass, Fast Atom Bombardment | 2 | 2000 | 7 | 0.080 |
Why?
|
Muscle, Skeletal | 3 | 1996 | 396 | 0.080 |
Why?
|
Aquaculture | 1 | 2008 | 4 | 0.080 |
Why?
|
Male | 7 | 2012 | 37321 | 0.080 |
Why?
|
Methylation | 1 | 2008 | 56 | 0.080 |
Why?
|
Kidney | 2 | 2008 | 945 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2008 | 46 | 0.080 |
Why?
|
Erythrocytes | 1 | 2008 | 137 | 0.080 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 120 | 0.080 |
Why?
|
Microbiological Techniques | 1 | 2007 | 9 | 0.070 |
Why?
|
Esterification | 1 | 2007 | 25 | 0.070 |
Why?
|
HIV Infections | 1 | 2015 | 791 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2007 | 33 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 694 | 0.070 |
Why?
|
Florida | 1 | 2008 | 221 | 0.070 |
Why?
|
Neurons | 1 | 2013 | 881 | 0.070 |
Why?
|
Genetic Variation | 1 | 2008 | 220 | 0.070 |
Why?
|
Caspase 3 | 2 | 2022 | 233 | 0.070 |
Why?
|
Microglia | 1 | 2008 | 143 | 0.070 |
Why?
|
Chloroquine | 1 | 2006 | 21 | 0.070 |
Why?
|
Oryzias | 1 | 2006 | 7 | 0.070 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 2006 | 3 | 0.070 |
Why?
|
Eukaryotic Cells | 1 | 2006 | 7 | 0.070 |
Why?
|
Toxicity Tests | 1 | 2006 | 26 | 0.070 |
Why?
|
Serotonin Agents | 1 | 2005 | 13 | 0.070 |
Why?
|
Receptors, Nicotinic | 2 | 1996 | 41 | 0.070 |
Why?
|
Reference Standards | 1 | 2006 | 115 | 0.070 |
Why?
|
Patents as Topic | 1 | 2005 | 4 | 0.070 |
Why?
|
Drug Resistance | 1 | 2006 | 223 | 0.060 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2005 | 26 | 0.060 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2005 | 58 | 0.060 |
Why?
|
Guanidine | 1 | 2004 | 7 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2004 | 47 | 0.060 |
Why?
|
Calcium Channels | 1 | 2005 | 59 | 0.060 |
Why?
|
Fourier Analysis | 1 | 2004 | 31 | 0.060 |
Why?
|
Survival Analysis | 1 | 2006 | 714 | 0.060 |
Why?
|
Biological Availability | 1 | 2004 | 79 | 0.060 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2001 | 59 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2004 | 87 | 0.060 |
Why?
|
Injections, Intravenous | 1 | 2004 | 215 | 0.060 |
Why?
|
Methanol | 1 | 2003 | 9 | 0.060 |
Why?
|
Eukaryota | 1 | 2003 | 10 | 0.060 |
Why?
|
Agrochemicals | 1 | 2003 | 3 | 0.060 |
Why?
|
Fibroblasts | 1 | 2008 | 902 | 0.050 |
Why?
|
Agaricales | 1 | 2003 | 2 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2022 | 11 | 0.050 |
Why?
|
Antarctic Regions | 1 | 2002 | 5 | 0.050 |
Why?
|
Phenylacetates | 1 | 2003 | 18 | 0.050 |
Why?
|
Quinolizines | 1 | 2002 | 4 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 1 | 2003 | 112 | 0.050 |
Why?
|
Sequence Analysis, Protein | 1 | 2002 | 16 | 0.050 |
Why?
|
Anticarcinogenic Agents | 1 | 2003 | 52 | 0.050 |
Why?
|
Alkaline Phosphatase | 1 | 2022 | 71 | 0.050 |
Why?
|
Endocrine Glands | 1 | 2002 | 7 | 0.050 |
Why?
|
Solvents | 1 | 2003 | 109 | 0.050 |
Why?
|
Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 10 | 0.050 |
Why?
|
Cold Temperature | 1 | 2002 | 90 | 0.050 |
Why?
|
Protein Conformation | 2 | 2014 | 362 | 0.050 |
Why?
|
Cell Fusion | 3 | 1996 | 23 | 0.050 |
Why?
|
Central Nervous System Agents | 1 | 2002 | 37 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 174 | 0.050 |
Why?
|
Phenols | 1 | 2022 | 73 | 0.050 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2001 | 9 | 0.050 |
Why?
|
Osteoblasts | 1 | 2022 | 99 | 0.050 |
Why?
|
Lipogenesis | 1 | 2021 | 9 | 0.050 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 67 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 1753 | 0.050 |
Why?
|
Necrosis | 1 | 2022 | 239 | 0.050 |
Why?
|
Drug Combinations | 1 | 2022 | 304 | 0.050 |
Why?
|
Toxoplasmosis | 1 | 2001 | 13 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 2083 | 0.050 |
Why?
|
Toxoplasma | 1 | 2001 | 23 | 0.050 |
Why?
|
Osteogenesis | 1 | 2022 | 152 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2013 | 85 | 0.050 |
Why?
|
Antioxidants | 1 | 2003 | 304 | 0.050 |
Why?
|
DNA, Bacterial | 2 | 2013 | 150 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 208 | 0.050 |
Why?
|
Tuberculosis | 1 | 2001 | 77 | 0.040 |
Why?
|
Phylogeny | 2 | 2013 | 197 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2000 | 72 | 0.040 |
Why?
|
Dimerization | 1 | 2000 | 99 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 514 | 0.040 |
Why?
|
Fatty Acids | 1 | 2000 | 222 | 0.040 |
Why?
|
Solanaceous Alkaloids | 1 | 1998 | 2 | 0.040 |
Why?
|
Aldehyde Reductase | 1 | 2018 | 3 | 0.040 |
Why?
|
PC12 Cells | 1 | 2018 | 36 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 67 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2022 | 1034 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2022 | 718 | 0.040 |
Why?
|
Proteolysis | 1 | 2018 | 97 | 0.040 |
Why?
|
Steroids | 1 | 2018 | 84 | 0.040 |
Why?
|
Plants, Toxic | 1 | 1997 | 33 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 139 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2019 | 382 | 0.040 |
Why?
|
Algorithms | 1 | 2003 | 1196 | 0.040 |
Why?
|
Brain | 1 | 2008 | 2176 | 0.040 |
Why?
|
Sophora | 1 | 2016 | 2 | 0.040 |
Why?
|
Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2016 | 2 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 314 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 791 | 0.030 |
Why?
|
A549 Cells | 1 | 2016 | 50 | 0.030 |
Why?
|
CDPdiacylglycerol-Serine O-Phosphatidyltransferase | 1 | 2016 | 2 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2016 | 6 | 0.030 |
Why?
|
Proton Magnetic Resonance Spectroscopy | 1 | 2016 | 27 | 0.030 |
Why?
|
HT29 Cells | 1 | 1996 | 42 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2016 | 80 | 0.030 |
Why?
|
Protein Domains | 1 | 2016 | 74 | 0.030 |
Why?
|
Potassium Channels | 1 | 1996 | 55 | 0.030 |
Why?
|
Tendons | 1 | 1996 | 45 | 0.030 |
Why?
|
Thermodynamics | 1 | 2016 | 162 | 0.030 |
Why?
|
Membrane Potentials | 1 | 1996 | 200 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 48 | 0.030 |
Why?
|
Potassium | 1 | 1996 | 168 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 2791 | 0.030 |
Why?
|
Cell Death | 1 | 2016 | 329 | 0.030 |
Why?
|
Renin | 1 | 1995 | 96 | 0.030 |
Why?
|
Endothelins | 1 | 1995 | 57 | 0.030 |
Why?
|
Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
Protein Binding | 1 | 2018 | 1027 | 0.030 |
Why?
|
Nicotinic Agonists | 1 | 1995 | 111 | 0.030 |
Why?
|
In Vitro Techniques | 3 | 2006 | 765 | 0.030 |
Why?
|
Pepsin A | 1 | 2014 | 8 | 0.030 |
Why?
|
Chymotrypsin | 1 | 2014 | 11 | 0.030 |
Why?
|
Water Pollution | 1 | 2014 | 10 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 2014 | 33 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2014 | 69 | 0.030 |
Why?
|
Trypsin | 1 | 2014 | 64 | 0.030 |
Why?
|
Cholinesterase Inhibitors | 1 | 2014 | 58 | 0.030 |
Why?
|
Biodiversity | 1 | 2013 | 16 | 0.030 |
Why?
|
Computer-Aided Design | 1 | 2014 | 101 | 0.030 |
Why?
|
Protein Stability | 1 | 2013 | 90 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2013 | 136 | 0.030 |
Why?
|
Veratridine | 1 | 2013 | 4 | 0.030 |
Why?
|
Sodium Channels | 1 | 2013 | 24 | 0.030 |
Why?
|
Ion Transport | 1 | 2013 | 26 | 0.030 |
Why?
|
Australia | 1 | 2014 | 235 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2013 | 56 | 0.030 |
Why?
|
Protein Folding | 1 | 2013 | 82 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2001 | 1173 | 0.030 |
Why?
|
Action Potentials | 1 | 2013 | 223 | 0.020 |
Why?
|
Patch-Clamp Techniques | 3 | 1996 | 204 | 0.020 |
Why?
|
Aspergillus fumigatus | 1 | 2011 | 27 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 306 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2012 | 175 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2010 | 37 | 0.020 |
Why?
|
Mediterranean Sea | 1 | 2009 | 1 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2013 | 415 | 0.020 |
Why?
|
Pentamidine | 1 | 2009 | 7 | 0.020 |
Why?
|
Leishmaniasis | 1 | 2009 | 4 | 0.020 |
Why?
|
Italy | 1 | 2009 | 36 | 0.020 |
Why?
|
Amphotericin B | 1 | 2009 | 26 | 0.020 |
Why?
|
Homeostasis | 1 | 2011 | 291 | 0.020 |
Why?
|
DNA Replication | 1 | 2010 | 167 | 0.020 |
Why?
|
Rhizome | 1 | 2008 | 3 | 0.020 |
Why?
|
Genes, rRNA | 1 | 2008 | 8 | 0.020 |
Why?
|
Hindlimb Suspension | 1 | 2007 | 11 | 0.020 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2007 | 45 | 0.020 |
Why?
|
Desipramine | 1 | 2007 | 47 | 0.020 |
Why?
|
Citalopram | 1 | 2007 | 30 | 0.020 |
Why?
|
Swimming | 1 | 2007 | 38 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 120 | 0.020 |
Why?
|
Cells, Cultured | 3 | 1996 | 2673 | 0.020 |
Why?
|
RNA, Transfer, Phe | 1 | 2006 | 1 | 0.020 |
Why?
|
Puromycin | 1 | 2006 | 3 | 0.020 |
Why?
|
Peptide Elongation Factor 2 | 1 | 2006 | 14 | 0.020 |
Why?
|
Ribosomes | 1 | 2006 | 23 | 0.020 |
Why?
|
Electrophysiology | 2 | 1996 | 160 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2006 | 271 | 0.010 |
Why?
|
Motor Activity | 1 | 2007 | 621 | 0.010 |
Why?
|
Fungicides, Industrial | 1 | 2003 | 7 | 0.010 |
Why?
|
Herbicides | 1 | 2003 | 24 | 0.010 |
Why?
|
Insecticides | 1 | 2003 | 43 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2003 | 122 | 0.010 |
Why?
|
Rifampin | 1 | 2002 | 45 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2003 | 114 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 1664 | 0.010 |
Why?
|
Transcription Factors | 1 | 2006 | 753 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 532 | 0.010 |
Why?
|
Herpesvirus 1, Human | 1 | 2001 | 30 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 351 | 0.010 |
Why?
|
Child, Preschool | 2 | 1996 | 3187 | 0.010 |
Why?
|
Libya | 1 | 1998 | 1 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1998 | 45 | 0.010 |
Why?
|
Mycobacterium | 1 | 1998 | 12 | 0.010 |
Why?
|
Charybdotoxin | 1 | 1996 | 1 | 0.010 |
Why?
|
Elapid Venoms | 1 | 1996 | 5 | 0.010 |
Why?
|
Tubocurarine | 1 | 1996 | 3 | 0.010 |
Why?
|
Potassium Channel Blockers | 1 | 1996 | 32 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1996 | 78 | 0.010 |
Why?
|
Aminopyridines | 1 | 1996 | 26 | 0.010 |
Why?
|
Acetylcholine | 1 | 1996 | 64 | 0.010 |
Why?
|
Carbachol | 1 | 1995 | 34 | 0.010 |
Why?
|
Evoked Potentials | 1 | 1996 | 61 | 0.010 |
Why?
|
Viper Venoms | 1 | 1995 | 8 | 0.010 |
Why?
|
Endothelin Receptor Antagonists | 1 | 1995 | 17 | 0.010 |
Why?
|
Receptors, Endothelin | 1 | 1995 | 30 | 0.010 |
Why?
|
Isoproterenol | 1 | 1995 | 163 | 0.010 |
Why?
|
Microtubules | 1 | 1995 | 104 | 0.010 |
Why?
|
Perfusion | 1 | 1995 | 131 | 0.010 |
Why?
|
Child | 2 | 1996 | 6405 | 0.010 |
Why?
|
Sulfonamides | 1 | 1995 | 141 | 0.010 |
Why?
|
Adolescent | 2 | 1996 | 8912 | 0.010 |
Why?
|
Infant | 1 | 1996 | 2891 | 0.010 |
Why?
|
Signal Transduction | 1 | 1995 | 2689 | 0.000 |
Why?
|
Middle Aged | 1 | 1996 | 21147 | 0.000 |
Why?
|
Adult | 1 | 1996 | 21403 | 0.000 |
Why?
|